CognitiveTwin: Robust Multi-Modal Digital Twins for Predicting Cognitive Decline in Alzheimer's Disease

• URL: http://arxiv.org/abs/2604.22428v1
• Date: Fri, 24 Apr 2026 10:40:51 GMT
• Title: CognitiveTwin: Robust Multi-Modal Digital Twins for Predicting Cognitive Decline in Alzheimer's Disease
• Abstract summary: We present CognitiveTwin, a digital twin framework that predicts patient-specific cognitive trajectories.<n>We trained and evaluated the framework using data from 1,666 patients in the TADPOLE dataset.
• Score: 0.2566571621858396
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Predicting individual cognitive decline in Alzheimer's disease (AD) is difficult due to the heterogeneity of disease progression. Reliable clinical tools require not only high accuracy but also fairness across demographics and robustness to missing data. We present CognitiveTwin, a digital twin framework that predicts patient-specific cognitive trajectories. The model integrates multi-modal longitudinal data (cognitive scores, magnetic resonance imaging, positron emission tomography, cerebrospinal fluid biomarkers, and genetics). We use a Transformer-based architecture to fuse these modalities and a Deep Markov Model to capture temporal dynamics. We trained and evaluated the framework using data from 1,666 patients in the TADPOLE (Alzheimer's Disease Neuroimaging Initiative) dataset. We assessed the model for prediction error, demographic fairness, and robustness to missing-not-at-random (MNAR) data patterns. ognitiveTwin provides accurate and personalized predictions of cognitive decline. Its demonstrated fairness across patient demographics and resilience to clinical dropout make it a reliable tool for clinical trial enrichment and personalized care planning.

Related papers

• Neural operator-based digital twins for modeling amyloid-$β$ and tau propagation and treatment optimization in Alzheimer's disease [13.799382465474617]
  We develop a data-driven framework that learns biomarker dynamics directly from clinical observations.<n>We achieve predictive accuracies of 87% for amyloid-$$ and 81% for tau.
  arXiv  Detail & Related papers  (2026-06-23T21:23:49Z)
• Transition-Based Digital Twin Modelling for Alzheimer's Disease under Sparse Longitudinal Data [4.4427416958561405]
  Alzheimer's disease (AD) progression is highly heterogeneous and is typically observed through sparse and irregular longitudinal data.<n>We present a personalised digital twin framework for AD prediction and scenario-based analysis using multimodal longitudinal data.
  arXiv  Detail & Related papers  (2026-06-08T15:54:10Z)
• Predicting Neuromodulation Outcome for Parkinson's Disease with Generative Virtual Brain Model [95.41752463487008]
  Parkinson's disease affects over ten million people worldwide.<n>Inter-individual variability limits empirical treatment selection, increasing non-negligible surgical risk and cost.<n>We bridge this gap with a pretraining-finetuning framework to predict outcomes directly from resting-state fMRI.
  arXiv  Detail & Related papers  (2026-03-31T02:36:10Z)
• Conditional Neural ODE for Longitudinal Parkinson's Disease Progression Forecasting [51.906871559732245]
  Parkinson's disease (PD) shows heterogeneous, evolving brain-morphometry patterns.<n>Modeling these longitudinal trajectories enables mechanistic insight, treatment development, and individualized 'digital-twin' forecasting.<n>We propose CNODE, a novel framework for continuous, individualized PD progression forecasting.
  arXiv  Detail & Related papers  (2025-11-06T20:16:33Z)
• Learning Patient-Specific Spatial Biomarker Dynamics via Operator Learning for Alzheimer's Disease Progression [9.499341016835121]
  Alzheimers disease (AD) is a complex, multifactorial neurodegenerative disorder.<n>Despite recent therapeutic advances, predictive models capable of accurately forecasting individualized disease trajectories remain limited.<n>Here, we present a machine learning-based operator learning framework for personalized modeling of AD progression.
  arXiv  Detail & Related papers  (2025-07-22T01:52:28Z)
• A Demographic-Conditioned Variational Autoencoder for fMRI Distribution Sampling and Removal of Confounds [49.34500499203579]
  We create a variational autoencoder (VAE)-based model, DemoVAE, to decorrelate fMRI features from demographics. We generate high-quality synthetic fMRI data based on user-supplied demographics.
  arXiv  Detail & Related papers  (2024-05-13T17:49:20Z)
• Predicting Parkinson's disease evolution using deep learning [1.4610685586329806]
  Parkinson's disease is a neurological condition that occurs in nearly 1% of the world's population. There is not a single blood test or biomarker available to diagnose Parkinson's disease. No AI tools have been designed to identify the stage of progression.
  arXiv  Detail & Related papers  (2023-12-28T10:30:54Z)
• HGIB: Prognosis for Alzheimer's Disease via Hypergraph Information Bottleneck [3.8988556182958005]
  We propose a novel hypergraph framework based on an information bottleneck strategy (HGIB) Our framework seeks to discriminate irrelevant information, and therefore, solely focus on harmonising relevant information for future MCI conversion prediction. We demonstrate, through extensive experiments on ADNI, that our proposed HGIB framework outperforms existing state-of-the-art hypergraph neural networks for Alzheimer's disease prognosis.
  arXiv  Detail & Related papers  (2023-03-18T10:53:43Z)
• Modeling Disease Progression in Mild Cognitive Impairment and Alzheimer's Disease with Digital Twins [0.0]
  Digital Twins are simulated clinical records that share baseline data with actual subjects. We show how Digital Twins simultaneously capture the progression of a number of key endpoints in clinical trials across a broad spectrum of disease severity.
  arXiv  Detail & Related papers  (2020-12-24T22:29:47Z)
• Learning transition times in event sequences: the Event-Based Hidden Markov Model of disease progression [4.12857285066818]
  We connect ideas from event-based and hidden Markov modelling to derive a new generative model of disease progression. Our model can infer the most likely group-level sequence and timing of events from limited datasets. We use clinical, imaging and biofluid data from the Alzheimer's Disease Neuroimaging Initiative to demonstrate the validity and utility of our model.
  arXiv  Detail & Related papers  (2020-11-02T15:13:03Z)
• UNITE: Uncertainty-based Health Risk Prediction Leveraging Multi-sourced Data [81.00385374948125]
  We present UNcertaInTy-based hEalth risk prediction (UNITE) model. UNITE provides accurate disease risk prediction and uncertainty estimation leveraging multi-sourced health data. We evaluate UNITE on real-world disease risk prediction tasks: nonalcoholic fatty liver disease (NASH) and Alzheimer's disease (AD) UNITE achieves up to 0.841 in F1 score for AD detection, up to 0.609 in PR-AUC for NASH detection, and outperforms various state-of-the-art baselines by up to $19%$ over the best baseline.
  arXiv  Detail & Related papers  (2020-10-22T02:28:11Z)
• Neuro-symbolic Neurodegenerative Disease Modeling as Probabilistic Programmed Deep Kernels [93.58854458951431]
  We present a probabilistic programmed deep kernel learning approach to personalized, predictive modeling of neurodegenerative diseases. Our analysis considers a spectrum of neural and symbolic machine learning approaches. We run evaluations on the problem of Alzheimer's disease prediction, yielding results that surpass deep learning.
  arXiv  Detail & Related papers  (2020-09-16T15:16:03Z)
• Learning Dynamic and Personalized Comorbidity Networks from Event Data using Deep Diffusion Processes [102.02672176520382]
  Comorbid diseases co-occur and progress via complex temporal patterns that vary among individuals. In electronic health records we can observe the different diseases a patient has, but can only infer the temporal relationship between each co-morbid condition. We develop deep diffusion processes to model "dynamic comorbidity networks"
  arXiv  Detail & Related papers  (2020-01-08T15:47:08Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.